What is the recommended antibiotic syrup for treating impetigo?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Antibiotic Syrup for Treating Impetigo

For treating impetigo in children, oral cephalexin syrup is the recommended first-line antibiotic when oral therapy is indicated, with alternatives including clindamycin or sulfamethoxazole-trimethoprim (SMX-TMP) when MRSA is suspected. 1

Types of Impetigo and Causative Organisms

  • Impetigo presents in two forms: bullous and non-bullous. Bullous impetigo is exclusively caused by toxin-producing Staphylococcus aureus, while non-bullous impetigo can be caused by S. aureus, Streptococcus pyogenes, or both. 1, 2
  • Non-bullous impetigo begins as erythematous papules that evolve into vesicles and pustules that rupture, forming honey-colored crusts on an erythematous base. 1
  • Bullous impetigo presents with fragile, thin-roofed vesicopustules that may rupture, creating crusted erosions. 2

Treatment Algorithm for Impetigo

Topical vs. Oral Therapy Decision

  • Limited lesions: Topical antibiotics (mupirocin or retapamulin) twice daily for 5 days are first-line therapy. 2, 3
  • Oral antibiotics are indicated when: 1
    • Patient has numerous or extensive lesions
    • During outbreaks affecting multiple people
    • When topical therapy fails after 3-5 days
    • When systemic symptoms are present

First-line Oral Antibiotic Options (Syrup for Children)

  • Cephalexin syrup: 25-50 mg/kg/day divided into 4 doses for 7 days (first-line for presumed methicillin-susceptible S. aureus) 1, 4
  • Dicloxacillin syrup: 25-50 mg/kg/day divided into 4 doses for 7 days (alternative first-line) 1

Alternative Oral Antibiotics (When MRSA is Suspected)

  • Clindamycin syrup: 20-30 mg/kg/day divided into 3 doses for 7 days 1, 4
  • Sulfamethoxazole-trimethoprim (SMX-TMP) syrup: 8-12 mg/kg/day (based on trimethoprim component) divided into 2 doses for 7 days 1
  • Doxycycline syrup: For children >8 years old, 2-4 mg/kg/day divided into 2 doses for 7 days 1, 4

Important Clinical Considerations

  • Penicillin alone is not effective for impetigo since it lacks adequate coverage against S. aureus, which is present in most cases. 2, 5
  • The duration of oral antibiotic therapy should be 7 days. 1, 4
  • Topical antibiotics have been shown to have similar efficacy to oral antibiotics for limited disease and cause fewer side effects. 3, 5
  • Oral antibiotics cause more side effects than topical treatments, particularly gastrointestinal effects. 3, 5
  • In areas with high MRSA prevalence, empiric therapy should cover MRSA until culture results are available. 1, 4
  • Systemic antimicrobials should be used during outbreaks of poststreptococcal glomerulonephritis to eliminate nephritogenic strains. 1

Special Populations and Precautions

  • Avoid tetracyclines (doxycycline) in children under 8 years due to risk of dental staining. 4
  • Consider cephalexin as a safe alternative for pregnant patients. 4
  • For patients with penicillin allergy, clindamycin or macrolides can be used, though resistance rates to erythromycin are rising. 1, 6

Prevention of Spread

  • Keep lesions covered with clean, dry bandages. 4
  • Maintain good personal hygiene with regular handwashing. 4
  • Avoid sharing personal items that contact the skin. 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Cefdinir for Bullous Impetigo Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Interventions for impetigo.

The Cochrane database of systematic reviews, 2004

Guideline

Treatment of Impetigo on Hand Lesions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Interventions for impetigo.

The Cochrane database of systematic reviews, 2012

Research

Diagnosis and treatment of impetigo.

American family physician, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.